Drysol

Quick links to important sections

Drysol

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Drysol

Property Description
Active ingredient Aluminum Chloride Hexahydrate
Form Topical Solution
Pharmacological class Topical Antiperspirant, Astringent
Common use Treatment of severe excessive sweating (Hyperhidrosis)
Origin Synthetic Inorganic Metallic Salt

What is Drysol and Its Pharmacological Class?

Drysol is a globally recognized prescription-only (Rx) topical solution that is definitively classified as a powerful topical antiperspirant and astringent. Its primary, non-systemic purpose is to provide an effective intervention for patients dealing with severe and persistent excessive sweating, known medically as hyperhidrosis.

Aluminum Chloride Hexahydrate solutions serve as a highly effective first-line therapy for focal hyperhidrosis. Aluminum chloride solutions are highly effective topical agents for controlling severe sweating, offering a high level of sweat control in a topical format. This product is clinically recognized for its potency, standing apart from standard over-the-counter antiperspirants because its high concentration necessitates medical oversight.


Core Composition: The Role of Aluminum Chloride Hexahydrate

The principal ingredient in the topical solution is Aluminum Chloride Hexahydrate, which is a synthetic inorganic metallic salt derivative. This product is a single-component product wherein the active ingredient is dissolved in an anhydrous ethyl alcohol base, which serves as a necessary vehicle. The high concentration of the Aluminum Chloride Hexahydrate is what allows this medicine to exert its potent clinical effect.

A key differentiating feature is its availability in specialized topical solution presentations, optimizing targeted administration. The mechanism of action involves the compound creating a physical obstruction in the sweat ducts. The salt forms a temporary plug within the duct, which stops the flow of sweat. This physical blockage, coupled with the product's astringent action, is the fundamental principle by which Drysol achieves its primary therapeutic aim: stopping the flow of sweat.

What side effects are possible with Drysol?

Possible Side Effects and Safety Information

The safety profile of Aluminum Chloride Hexahydrate topical solution, as defined by government regulatory labeling, is primarily characterized by localized dermatological reactions and specific use restrictions. The adverse effects are mostly confined to the application site.


Adverse Reaction Scope

Classification Officially Documented Effects
Common / Frequent Local skin irritation, pruritus (itching), burning sensation, transient stinging, redness, and tingling (1.6). These are the most frequently reported adverse effects (1.6).
Rare Signs of a systemic hypersensitivity reaction, which is a severe allergic response (1.1).

The major adverse reaction categories involve Skin and Subcutaneous Tissue Disorders. Systemic Immune System Disorders are associated with the rare occurrence of allergic reactions (1.2).


Safety and Population Constraints

Serious Adverse Reactions: Regulatory warnings list systemic hypersensitivity as a serious adverse reaction (1.2). This includes swelling of the face, lips, tongue, or throat, or difficulty breathing (1.1).

Safety Restrictions: The product must not be applied to broken, irritated, or recently shaved skin to mitigate the risk of severe local irritation (1.7). Furthermore, use is contraindicated in individuals with a known hypersensitivity to any component of the formulation (1.7).

Population Considerations: Caution is advised regarding use during pregnancy and lactation due to insufficient data for establishing safety (1.7). The label also advises caution for patients with renal impairment due to the potential for minimally increased aluminum exposure (1.4).

Local effects, such as itching or mild burning, may be noted when the solution is first applied or at the start of treatment (1.1).


This framework establishes the boundaries and limitations for the use of the topical solution, guiding the safe administration of the product by outlining expected frequent local reactions and necessary precautions.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Aluminum Chloride Hexahydrate topical solution emphasizes that the risk of overdose centers on accidental oral ingestion, as systemic toxicity is not generally anticipated with correct topical application.

Documented Manifestations

Overdose manifestations are primarily associated with the corrosive nature of the substance when swallowed. Ingestion can cause severe local injury to the gastrointestinal tract, commonly presenting as nausea and profound vomiting. In cases involving the ingestion of large quantities, systemic toxicity may occur, leading to signs of aluminum accumulation. Documented severe outcomes include potential CNS effects such as confusion and seizures, as well as possible liver damage.

Required Emergency Actions

Regulatory guidance strictly mandates that individuals seek immediate emergency medical attention or contact a Poison Control Center immediately if the solution is known or suspected to have been swallowed. Due to the corrosive potential, the official instructions are to NOT induce vomiting. Management is limited to symptomatic and supportive treatment, as regulatory labels confirm that no specific antidote is known for this overdose.

Therapeutic Uses of Drysol

What Drysol Treats: Main Uses and Benefits

Drysol is commonly used for managing Primary Focal Hyperhidrosis, applied in addressing the chronic and often severe excessive sweating concentrated in specific areas. The medication may be relevant for easing symptoms related to localized excessive moisture in the underarms, palms, and soles. High-strength aluminum chloride products are recognized as part of symptomatic management for this condition.

This prescription-strength solution is commonly used across conditions presenting with heightened symptoms that are not relieved by conventional topical applications. It assists with managing symptoms that interfere with daily comfort and may create noticeable functional strain. The therapeutic benefit supports patients during episodes of heightened discomfort that relate to functional stability and psychosocial distress.

“The primary therapeutic area involves symptom management that helps improve day-to-day comfort.”

Quick Fact: Relief for Localized Excessive Moisture Drysol is applied in contexts marked by increased discomfort where short-term symptomatic assistance is needed to control chronic, high-output sweating. It offers symptomatic relief that helps patients cope with difficult symptomatic periods.

Regulatory References

  1. NIH MedlinePlus overview of Hyperhidrosis treatment

Eligibility and Restrictions for Use

Who Can and Cannot Use Drysol?

This section outlines the official population-eligibility rules and restrictions for Drysol (Aluminum Chloride Hexahydrate) as defined in government regulatory documents and prescribing information. Eligibility is based on age, specific medical conditions, and skin integrity.


Contraindications and Restrictions

Condition/Group Status (Regulatory Wording)
Hypersensitivity/Allergy Contraindicated in patients with known allergy to any component.
Broken, Irritated, or Shaved Skin Must not be applied to skin that is broken, irritated, or recently shaved.
Children/Infants Safety and effectiveness have not been determined. Use is not established.

Conditional Use Populations

Condition/Group Status (Regulatory Wording)
Renal Impairment Consult a clinician before use (due to concerns regarding potential aluminum absorption).
Pregnancy Not recommended unless the clinician determines use is clearly needed.
Lactation Use with caution, as excretion into breast milk is unknown.

Use is established for Adults and Adolescents under standard labeled conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Aluminum Chloride Hexahydrate topical solution (Drysol) is primarily defined by local administration restrictions and the composition of its vehicle, rather than systemic drug-drug interactions.

Interaction Scope and Restrictions

Interaction Type Interacting Substance/Product Regulatory Restriction
Local Pharmacodynamic Other topical antiperspirants or deodorants Mandatory Restriction: Must not be co-administered on the same treatment area.
Vehicle-Related Caution Systemic drugs (e.g., Disulfiram, Metronidazole, Tinidazole) Caution regarding co-administration due to the formulation's anhydrous ethyl alcohol solvent, which carries a theoretical risk for a disulfiram-like reaction.
Population-Specific Note Renal Impairment A caution exists for patients with kidney impairment due to the potential for reduced clearance of any systemically absorbed aluminum.

No systemic pharmacokinetic interactions (such as those mediated by CYP enzymes or drug transporters) are detailed in the official product labeling. The absence of these interactions is consistent with the minimal systemic absorption of the active ingredient from the topical application site. The mandatory separation rule for other topical agents prevents local adverse effects.

Mechanism of Action

The mechanism of Aluminum Chloride Hexahydrate is localized and relies on a physical, chemical reaction rather than complex systemic pharmacology.

Physicochemical Occlusion of the Eccrine Duct

The aluminum ions ( Al^3+) chemically react with keratin and mucin proteins lining the distal eccrine sweat duct and in the secreted sweat, causing them to denature and precipitate. This precipitation forms a dense, temporary aluminum-protein plug that physically seals the duct's lumen, resulting in the occlusion of the fluid transport pathway.

Pressure-Mediated Glandular Suppression

This domain addresses the resulting physiological cascade. The physical sealing of the duct leads to a rapid increase in intraductal pressure behind the plug, which acts as a local pressure-feedback signal. This pressure functionally signals the deeper secretory coil of the eccrine gland to temporarily cease or decrease its production of sweat, resulting in suppressed eccrine gland output.

Dosage and Administration Information

How to Use Drysol

Drysol, a prescription-strength topical solution containing Aluminum Chloride Hexahydrate, is administered directly to the skin surface in two distinct phases. This administration protocol is characterized by specific timing and application conditions.


Official Usage Regimen

The usage protocol is divided into an initial intensive phase and a subsequent maintenance phase. The product is consistently applied at bedtime when sweat glands are least active, allowing the solution to remain on the skin for an effective duration.

Feature Clinical Parameters
Route of Administration Topical application to the skin.
Initial Regimen Apply sparingly once daily until control of excessive sweating is achieved (typically after 2 or more treatments).
Maintenance Regimen Reduce frequency to once or twice weekly, or as needed to maintain the effect.
Age-Group Rule The same application regimen is used for adolescents and geriatric patients.

Administration Conditions and Procedural Structure

The application process is constrained by two critical procedural steps to ensure proper use:

  1. Preparation: The solution must be applied only to completely dry skin. Any moisture may affect the application.
  2. Duration & Removal: The solution must be left on the skin for 6 to 8 hours (overnight) and then washed off thoroughly with soap and water the following morning.

This structured, two-phase regimen and mandatory application conditions define the method for using the prescription topical solution.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Drysol

Evidence for Use in Underarm (Axillary) Sweating

Research has examined the use of high-concentration aluminum chloride solutions for excessive sweating of the underarms, medically known as axillary hyperhidrosis. The evidence base includes randomized controlled studies and other controlled trials, where a treated underarm is often compared directly to an untreated or placebo underarm. These studies monitored adults who experience this condition.

Studies focusing on this body area often monitored changes in localized sweat output during the initial weeks of application, with findings describing patterns of change. These findings describe patterns observed in the studies that contribute to the broader evidence landscape for topical strategies for this condition. These results reflect the specific conditions under which the studies were conducted; findings describe group patterns, not personal outcomes.


Evidence for Use in Hand and Foot (Palmar and Plantar) Sweating

Research has also explored the application of this medicine for excessive sweating of the palms (palmar) and soles (plantar). The studies conducted for these sites included controlled trials and observational studies, often involving adults whose condition was marked by functional limitations related to moisture.

Findings were mixed across studies for the palmar and plantar sites. Research describes that the need for specific application techniques was noted in some studies to achieve a measured change. Studies examined whether the consistency of observed patterns was different from what was reported for axillary sweating. Evidence quality varies across studies for these specific anatomical locations.


Research Gaps and Areas of Uncertainty

Studies generally focus on short-term symptom patterns. Research has explored intermediate follow-up durations, monitoring the medicine over approximately one to three months to assess the intervals needed to sustain the relief. However, long-term effects are not fully established by controlled trials.

Key limitations include that many of the core studies involved sample sizes that were modest. This means that results apply only to the populations studied and may not be fully generalizable. Data for certain special groups, such as children and adolescents, remain insufficient.

Frequently Asked Questions (FAQ)

Common questions about Drysol (FAQ)


Q: What does it mean for a medicine like Drysol to be 'first-line treatment'?

Being described as a first-line therapy means that official medical treatment guidelines often recommend a topical aluminum chloride solution as the initial, most established approach for focal excessive sweating (hyperhidrosis). Reviews note that this compound is considered a highly effective topical strategy for controlling severe sweating.


Q: Why does Drysol sometimes cause itching or irritation?

Regulatory documents indicate that the active ingredient in the product can react chemically when exposed to water, which results in acidity. For this reason, the official application instructions define that the product must be applied only to completely dry skin. Adhering to this application condition can help minimize the risk of localized adverse effects like irritation, stinging, and a burning sensation.


Q: Are there any known issues with using Drysol and certain skin creams or lotions?

Official regulatory guidance focuses primarily on restrictions against using other topical antiperspirants or deodorants on the same area. However, official caution states that no other skin products (including creams or lotions) are generally not recommended to be used on the affected area without first consulting a clinician.


Q: Are there different strengths of Drysol available?

According to official product information, aluminum chloride topical solutions are available in different concentrations, such as 6.25%, 15%, and 20%. The higher concentration formulations are commonly referenced in product documentation for application to areas like the underarms, palms, and soles.


Q: Can Drysol cause skin discoloration or staining on clothing?

Official warnings state the product may stain clothing or fabric and also notes that it may be harmful to some metals. Thoroughly washing the treatment area with soap and water the morning after application is part of the required procedure. This step is designed to help avoid potential damage to clothing and surrounding materials.


Q: What is the typical duration of effect after a person stops using Drysol?

Studies have examined the effect of discontinuing the product. Research focusing on application to the palms has described that the effects of reduced sweating may begin to diminish or disappear within 48 hours after therapy is stopped. To maintain the effect, official instructions define a regular maintenance regimen.


Q: Do studies support the use of Drysol in teenagers?

The same official application regimen used for adults is also used for adolescents. However, official information notes that while use may be established, controlled trial data specifically addressing the full safety and effectiveness in the adolescent population remains insufficient.


Q: Has there been research comparing Drysol to other aluminum chloride products?

Studies have examined and compared different aluminum chloride solutions. Research has been published on solutions at various concentrations, such as 6.25%, 12%, and 20%, to examine their effectiveness in managing excessive sweating in dermatology.


Q: Is the active ingredient in Drysol found in other types of medicines?

The active ingredient, Aluminum Chloride Hexahydrate, is classified as a topical antiperspirant and an astringent agent. Due to its astringent property (the ability to constrict or tighten tissue), it is also noted for applications in products like styptic pencils, which are used to stop minor bleeding.


Q: What should be done if the area where Drysol is applied feels dry or flaky?

Localized reactions such as irritation, stinging, or burning are listed as common side effects. Official guidance indicates that these effects usually resolve with temporary discontinuance of the product. If any localized effects such as irritation, dryness, or flakiness are persistent or become worse, a clinician should be consulted.


Q: Does Drysol have a strong odor or scent?

The active ingredient itself is generally described as odorless in its base form. However, the formulation contains a high concentration of anhydrous ethyl alcohol, which serves as the liquid vehicle.


Q: Are there any special warnings listed for individuals with kidney or liver conditions?

Official product information advises caution for patients with renal impairment (kidney conditions). This is due to the potential for minimally decreased clearance and increased exposure to any absorbed aluminum. Specific guidelines for hepatic (liver) impairment dosage adjustments are generally not available in the official labeling.


Q: Is it true that the efficacy of Drysol can be affected by shaving?

Regulatory warnings focus on safety, stating the product must not be applied to recently shaved skin. This rule is in place to mitigate the risk of severe local irritation. Official documents do not explicitly address whether shaving affects the medicine's effectiveness.


Q: What is the difference between an antiperspirant and a deodorant, and which is Drysol?

Drysol is classified as a powerful topical antiperspirant and astringent. An antiperspirant is designed to reduce or stop the flow of sweat. Official product labeling mandates that other deodorants or antiperspirants must not be used on the same treatment area at the same time.


Q: Is Drysol covered by insurance plans, and how is it classified?

Drysol is classified as a prescription-only (Rx) medication and falls under the pharmacological category of Topical Antiperspirants. As with other prescription products, whether it is covered often depends on the specifics of an individual's insurance plan or formulary.


Q: What are common user questions related to accidentally using too much Drysol?

Regulatory information indicates that an overdose from topical application is not generally expected to be dangerous. However, the solution contains high concentrations of alcohol. If the medication is accidentally swallowed or if large amounts are inhaled, official warnings state that immediate emergency medical attention is required.


Q: Do any official documents discuss the possibility of Drysol causing a rash?

Official documents list various localized reactions such as redness, burning, and irritation. Furthermore, warnings for serious adverse reactions explicitly list skin rash and hives as potential signs of a systemic allergic reaction that must be addressed immediately by a clinician.


Q: Are there any specific product types (e.g., cleansers, exfoliants) that should not be used with Drysol?

The specific regulatory restriction is against other topical antiperspirants or deodorants. Official caution also advises that the use of any other skin products on the affected area, including cleansers or exfoliants, should first be discussed with a clinician.


Q: Are there any general expectations about how Drysol affects sweating across a 24-hour period?

The product is applied at night and left on for several hours. According to product information, a reduction in sweating is generally observed within one to two treatments (24 to 48 hours). The effect is designed to be maintained by following the prescribed, scheduled application during the maintenance phase.


Q: What are the general differences in how Drysol is used compared to oral medications?

Drysol is a solution used through topical administration, meaning the active ingredient is applied directly to the site of action on the skin. This contrasts with oral administration, where medications are swallowed and typically absorbed into the bloodstream before being distributed throughout the body.


Q: Is the vehicle (liquid/dabber) Drysol comes in important for how it works?

The active ingredient is dissolved in an anhydrous ethyl alcohol vehicle. The use of a solvent that is free of water is considered key to the product’s function. Applying the solution to completely dry skin prevents the aluminum chloride from reacting prematurely on the skin’s surface before it can enter the sweat ducts.

How should Drysol be stored and disposed of?

How to Store and Dispose of Drysol?

Drysol (aluminum chloride hexahydrate) topical solution requires careful storage and handling, primarily due to its flammability and high alcohol content. The medication must be kept at controlled room temperature, which is between 20 C and 25 C (68 F and 77 F).

Storage Requirements:

  • Store Drysol in a dry place, away from heat, sparks, or open flames, as it is a highly flammable liquid.
  • Keep the original container tightly closed when not in use to prevent evaporation and maintain product stability.
  • Always store the product out of the reach of children and pets.

Disposal Instructions:

  • Do not pour Drysol down a sink or toilet.
  • The preferred method of disposal is through a medicine take-back program.
  • If no take-back program is available, mix the medication with an undesirable substance, such as dirt or used coffee grounds, seal the mixture in a plastic bag, and dispose of it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Drysol found in:

A-Z Index: